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REZUMAT
SUPRAINFECTIA BACTERIANA A INFECTIILOR RESPIRATORII VIRALE
Actualitatea temei. Suprainfecţia bacteriană a infecţiilor respiratorii virale este un fapt confi rmat, atât prin diagnos-
ticul clinic, cât și cel molecular. Material și metodă. Au fost luate în considerare studiile care au rectrutat pacienţi de 
vârstă pediatrică în vederea identifi cării virale, bacteriene, precum și coinfecţia viro-bacteriană și suprainfecţia bacte-
riană a infecţiilor respiratorii virale premonitorii. Rezultate. Studiile au consemnat creșterea incidenţei patogenilor 
virali odată cu dezvoltarea tehnicilor de detecţie moleculară, modifi carea etiologiei bacteriene odată cu introducerea 
vaccinării conjugate antipneumococice. Coinfecţia viro-bacteriană sau prezenţa concomitentă a mai multor tulpini 
virale cresc severitatea bolii, cu o staţionare de lungă durată în unităţile de terapie intensivă. Concluzii. Suprainfecţia 
bacteriană a infecţiilor respiratorii virale rămâne un fapt, cu implicare terapeutică și evolutivă. Cuvinte cheie: pato-
genii respiratori virali și bacterieni, infecţia respiratorie virală, coinfecţia viro-bacteriană, suprainfecţia bacteriană.
SUMMARY
BACTERIAL SUPERINFECTION OF THE RESPIRATORY VIRUSES
Th eme topicality. Bacterial superinfection of the respiratory viruses is a confi rm fact, either by clinical diagnosis, and 
molecular one. Material and methods. It were considered some studies which have been recruited pediatric patients 
for viral and bacterial identifi cation, also for viral and bacterial coinfection and superinfection of the premonitory 
viral respiratory infection. Results. Th e studies have been recorded an increase incidence of viral pathogens with the 
improvement of molecular detection techniques, and the bacterial etiology changes with the introduction of conjugate 
pneumococcal vaccin. Viral and bacterial coinfection or the concomitant presence of a multiple viral strains increase 
the severity of disease, with a long length-of-stay in pediatric intensive care units. Conclusions. Bacterial superinfection 
of viral respiratory infection remains a fact, with therapeutic and evolutive implication. Keywords: viral and bacterial 
respiratory pathogens, viral and bacterial coinfection, bacterial superinfection.
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Introduction
Viral infection-bacterial infection relationship (coin-
fection, superinfection). In prevaccinal era (conjugate 
pneumococcal vaccin), S. Pneumoniae was considered 
bacteriologic leader causing lower airways infection, 
respectively pneumonia (community-acquired)4. S. 
Pneumoniae has followed, as frequency, by Haemophylus 
infl uenzae, Streptoccocus pyogenes, Staphiloccocus 
aureus and Moraxella catarrhalis. Enteric gram-nega-
tive bacteria and those intracellular and atypical (Myco-
plasma pneumoniae şi Chlamydophila pneumoniae)13,15,25 
were also reported. With introduction of multi-valent 
and conjugate haemophilus and pneumococcal vaccine, 
the frequency of community-acquired pneumonia was 
signifi cant reduced in countries with a complete national 
program of vaccination. In developing countries, with an 
incomplete vaccine program, bacteria remains the main 
etiologic factor of community-acquired pneumonia.
With the improvement of molecular diagnosis, viruses 
with respiratory tropism are detected with a higher 
frequency in children diagnosed with pneumonia, espe-
cially those younger than 5 years. Th e most frequent 
viruses are respiratory syncytial virus, infl uenza, parain-
fl uenza, rhinovirus and adenovirus12. Th e newest molec-
ular techniques have allowed identifi cation of metap-
neumovirus, human coronavirus, and human bocavirus. 
In industrialized countries up to 81 % children with 
community-acquired pneumonia claim viral etiology, 
especially respiratory syncytial virus (up to 48 %). 
It exists more and more evidences regarding the important 
role of respiratory viruses in facilitating bacterial colo-
nization in child. Most of those refer to lower airways 
infection, respectively pneumonia (community-acquired 
pneumonia). Th e mechanism is not totally known, either 
the faciliting bacterial colonization is producing directly, 
or viruses contribute of development of severe forms of 
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disease. Viruses make a vulnerability of host respiratory 
epithelium, thus favoring the initiation of respiratory 
bacterial infection. If the bacterial etiology is signifi cant 
infl uenced by conjugate pneumococcal vaccine, S. pneu-
moniae infection being the leader of bacterial infection, 
the viral etiology being infl uenced only by improvement 
of viral techniques detection, the most frecquent viruses 
have been infl uenza, respiratory syncytial virus, parain-
fl uenza and adenovirus30,31. And the invazive pneumo-
coccal infection has observed mostrly in the context of 
viruses19. Th e proof of viral and bacterial coinfection is 
certain, in or not directly relationship with bacterial 
superinfection of respiratory viral infection. A trial made 
in South Africa which included children with conjugate 
pneumococcal vaccination has proven a decrease of 
pneumonia with S. pneumoniae incidence, also of viral 
pneumoniae, just in context of respiratory viruses and 
pneumococcus relationship26,27. Much more than that, 
the Australian12 statistical data have shown a decrease 
of viral pneumonia incidence as eff ect of pneumococcal 
vaccination. Th e respiratory syncytial virus has recorded 
as favorable factor of bacterial colonization with H. infl u-
enzae and S. aureus in 25 % of hospitalized patients with 
severe form of A type infl uenza infection during 2000 
pandemia2,3. Th e patients which have presented viral and 
bacterial coinfection have presented a severe evolution, 
with ventilator support and long length-of-stay in inten-
sive care unit23,24.
Metodology. Th e relationship between naso-pharyn-
geal pathogens and the form of severity of lower airways 
infection has studied in a couple of clinical studies. 
Th e naso-pharyngeal pathogens could be considered 
as predictive factors for pneumonia severity in child. 
A study made in USA has demonstred a link between 
respiratory syncytial virus infection and long hospital-
ization, respiratory failure and intensive treatment. In 
Vietnam, children with radiologic confi rmed pneumonia 
were detected with pneumococcal infection in a much 
larger proportion than other etiology, and the pneumo-
coccus presence was 15 times more in patients with viral 
and bacterial coinfection. Other studies, in Kenya and 
Holland have reported a nasopharyngeal load of respi-
ratory syncytial virus in children with severe forms of 
disease.
In comparison with many studies with the same target 
– the determination of community-acquired pneumonia 
etiology, a few studies have included healthy children 
or asymptomatic ones, as control group. Th e naso-pha-
ryngeal carriage was frequent associated with healthy 
children or asymptomatic ones. Are required studies 
which must use supplement investigation to certify that 
asymptomatic carriage is a fact in healthy population, 
and its involvement in community-acquired pneumonia 
become a challenge. 
Although the conjugate pneumococcal vaccination has 
reduced a lot the hospitalization rate of community-ac-
quired pneumonia in industrialized countries, pneu-
mococcus remains an important pathogen regarding 
non-vaccin serotype with severe and complicate pneu-
monia potential (inclusively, empiema). 
Th e incidence of viral infection, bacterial infection, ciral 
and bacterial coinfection and bacterial superinfection 
varies according to level of income country, patient age 
and utilized sample (naso-pharyngeal fl uid, sputum, 
broncho-alveolar fl uid)32.
Results. Start with 1993-1995 period, in Finland22, a 
study which included children younger than 18 years, 
diagnosed with community-acquired pneumonia has 
shown the presence in naso-pharyngeal aspiration of viral 
pathogen in 62 percent, and of a bacterial pathogen in 53 
percent. Th e pathogens frequency was: S. pneumonie 37 
%, respiratory syncytial virus 29 %, human rhinovirus 24 
%, parainfl uenza 10 %, H. infl uenzae 9 %, adenovirus and 
M. pneumoniae each one 7 %, infl uenza and Moraxella 
catarrhalis each one 4 %. 
Th e other study29, performed in 1999-2000 period, made 
in USA, which included children 6 weeks-17 years old, 
diagnosed with pneumonia, has showed the following 
pathogens in naso-pharyngeal aspirate: S. pneumoniae 
44 %, infl uenza 21 %, M. pneumoniae 14 %, respiratory 
syncytial virus and parainfl uenza each 13 %, Cham-
ydophila pneumoniae 9 %, adenovirus 7 %, rhinovirus 
3 %. 
In 2001-2002 period were performed two studies:
– in Italy10, children 3 months-16 years old, diagnosed 
with pneumonia, used naso-pharyndeal swab and 
blood culture as a detection methods (M. pneumo-
niae 27 %, S. pneumoniae 18 %, human parainfl uenza 
12 %, infl uenza 9 %, human metapneumovirus 5 %);
– in Japan36, children 1 month-13 years old, diagnosed 
with pneumonia, used naso-pharyngeal swab and 
blood culture as a detection methods (respiratory 
syncytial virus 48%, S. pneumoniae 36 %, H. infl u-
enzae 26 %, infl uenza 22 %, M. pneumoniae 17 %, 
parainfl uenza 14 %).
In 2003-2005 period, în Switzerland5, was initiated a 
study which recruited children 2 months-5 years old, 
diagnosed with pneumonia. Th e results revealed the 
presence in the naso-pharyngeal aspirate of the following 
respiratory pathogens: bacteria, 72 percent (S. pneumo-
niae, 46 %; M. pneumoniae, 11 %; C. Pneumoniae, 7 %) 
and viruses, 67 percent (human rhinovirus, 20 %; infl u-
enza, 14 %; respiratory syncytial virus and human metap-
neumovirus, each 13 %; adenovirus, 7 %).
Other study, performed in 2004-2006 period, in Spain8, 
recruted children younger than 3 years, diagnosed with 
pneumonia, use for pathogen detection naso-pharyn-
geal aspirate. Th e study showed the following results: 
viral and bacterial coinfection (30 %), viruses 67 percent 
(respiratory syncytial virus 20 %, human bocavirus and 
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rhinovirus each 14 %, human metapneumovirus 12 %, 
parainfl uenza 11 %, infl uenza 7 %). 
A study from USA34, performed between 2005-2007 
period, with patients younger than 3 years, revealed the 
following:
– for diagnosis of airways infection, with samples from 
blood and naso-pharyngeal swab, were identifi ed 
viral pathogens in 90 percent (human rhinovirus 44 
%, adenovirus 30 %, respiratory syncytial virus 23 %, 
parainfl uenza 18 %, human metapneumovirus 15 %) 
and bacteria in 3 percent (S. pneumoniae 2 %);
– for asymptomatics, with samples from naso-pharyn-
geal swab, were identifi ed viral pathogens in 52 
percent (human rhinovirus 33 %, adenovirus 16 %, 
human metapneumovirus 7 %, respiratory syncytial 
virus 4 % and parainfl uenzae 3 %).
Th e same diff erentiation, children with respiratory infec-
tion and asymptomatics, was performed in a study from 
Holland20, in 2007-2009 period, children younger than 6 
years, with samples collected from nasal fl uid:
– for airways infection, the viral pathogens were 
present in 72 percent (respiratory syncytial virus 26 
%, human rhinovirus 20 %, adenovirus 9 %, metap-
neumovirus and infl uenza each 6 %);
– for asymptomatics, the viral pathogens were present 
in 26 percent (human rhinovirus 16 %, adenovirus 9 
%, human coronavirus 5 %, infl uenza 3 % and respi-
ratory syncytial virus 1 %).
In 2006-2007 period, in Finland16, was initiated a study 
which recruited children 6 months-15 years old, diag-
nosed with pneumonia. Th e results revealed the sputum 
presence of the following pathogens: bacteria, 91 percent 
(S. pneumoniae, 50 %; H. infl uenza, 38 %; S. aureus, 13 
%) and viruses, 72 percent (human rhinovirus, 30 %; 
bocavirus, 18 %; metapneumovirus, 14 %, parainfl uenza, 
8 %; respiratory syncytial virus, 7 %).
A study performed in Holland35, in 2008-2011 period, 
with patients 3 months-16 years old, showed the 
following: 
– for airways infection, with samples from blood and 
naso-pharyngeal swab, were identifi ed bacterial 
pathogens (S. pneumoniae 28 %, Moraxella catarr-
halis 23 %, M. pneumoniae and H. infl uenzae each 16 
%, S. aureus 10 %);
– for asymptomatics, with samples from blood and 
naso-pharyngeal swab, were identifi ed bacterial 
pathogens (S. pneumoniae 28 %, M. pneumoniae 
21 %, S. aureus 21 %, Moraxella catarrhalis 18 %, H. 
infl uenzae 15 %).
Other study performed in USA18, between 2010-2012, 
with patients younger than 18 years, evidentiated the 
following: 
– for pneumonia diagnosis, with samples from blood 
and naso-pharyngeal swab, were identifi ed viral 
pathogens in 66 percent (respiratory syncytial virus 
28 %, human rhinovirus 27 %, human metapneu-
movirus 13 %, adenovirus 11 % and infl uenza 7 %), 
bacterial pathogens in 8 percent (M. pneumoniae 8 % 
and S. pneumoniae 4 %);
– for asymptomatics, with samples from naso-pharyn-
geal swab, were identifi ed viral pathogens represented 
by human rhinovirus in 17 percent (other viruses, less 
than 3 % percent); viral and bacterial coinfection was 
identifi ed in 7 percent. 
A study performed in Sweden33, in 2011-2014 period, in 
children younger than 5 years, has shown the following 
results:
– in children with pneumonia, from naso-pharyngeal 
aspirate, were identifi ed viral pathogens in 81 percent 
(respiratory syncytial virus 32 %, human metapneu-
movirus and human rhinovirus each 23 % and adeno-
virus 15 %)
– in asymptomatic, from naso-pharyngeal swab, were 
identifi ed viral pathogens in 56 percent (human 
rhinovirus 27 %, human bocavirus 21 %, coronavirus 
12 %, adenovirus 7 %, respiratory syncytial virus 6 %).
Disscusions. As can be seen in the presented studies the 
frequency of respiratory pathogens varies from country 
to country, according with income level, vaccination 
program, detection methods used, samples used. Over the 
decades, with the conjugate pneumococcal vaccine initi-
ation, the S. pneumoniae frequency signifi cant decreased 
(from 37 % to 4 %). According as, with the improvement 
of molecular detection techniques, the frequency of viral 
pathogens increased. Th e last years studies propose as 
target the viral and bacterial coinfection detection. 
Th e distribution of identifi ed pathogens in commu-
nity-acquired pneumonia is variable from country to 
country1,11,17,21,28. Th us: 
– for viral pathogens
• respiratory syncytial virus was detected in a high 
percent in Kenya (34 %), Nigeria (30,4 %) and 
USA (28 %) and almost insignifi cant in Gambia 
(4 %);
• rhinovirus was detected in a high percent in USA 
(27 %) and much less in Great Britain (8,5 %)
• human metapneumovirus, the most detected in 
USA (13 %) and insignifi cant in Great Britain (0,7 
%)
• infl uenza, in the same percent of detection 
(between 2 and 7,4 %), knowing the fact that 
both the virus and the vaccine have the strongest 
impact in community 
• bocavirus was reported in a less percent and only 
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in a few countries (3,3 %, in Great Britain and 4 %, 
in Gambia)
• adenovirus presented the most important detec-
tion in USA (11 %)
• parainfl uenza, with the big rate of detection in 
Nigeria (19,5 %)
– for bacterial pathogens
• S. pneumoniae, detected in an extreme percent 
in Gambia (91 %), and in the opposite percent in 
USA (4 %)
• H. infl uenzae, detected in 23 percent in Gambia 
and 2,3 percent in Great Britain
• A Streptococcus, detected in 10,5 percent in Great 
Britain and 1 percent in USA
• S. aureus, detected in an important percent only 
in Nigeria
• M. pneumoniae, (8-9,9 percent)
• Moraxella catarrhalis, in 2,3 percent in Great 
Britain
• Klebsiella pneumoniae, 15,3 percent in Nigeria 
and insignifi cant one in Great Britain (0,8 
percent).
Th e results per se are infl uenced by sample methods 
of detection of respiratory pathogens. Th is stage of 
diagnosis (molecular diagnosis) become very important, 
especially in the situation when clinics and radiologic 
exam are not able to sustain the diagnosis of pneumonia 
(community-acquired). 
Th e British Th oracic Society and Th e Infectious Disease 
Society of America guidelines recommend the PCR 
virusal tests or immunofl uorescence, while for bacterial 
detection the methods varied according to the forms of 
gravity of infection. 
In Great Britain are used the following tests: blood 
culture, real-time PCR, naso-pharyngeal fl uid, pleural 
culture, pneumococcal antigen test, endotracheal tube 
aspirate, broncho-alveolar fl uid. 
In USA are used the following tests: blood culture, 
naso-pharyngeal fl uis, oro-pharyngeal fl uis, pleural 
culture, broncho-alveolar fl uid, culture from endotra-
cheal tube aspirate. 
In Gambia are used the following tests: culture from 
broncho-alveolar and pleural fl uid for non-molecular 
serotypes, uniplex and multiplex PCR, multilocular sequ-
ence typing, molecular serotyping.
Th e virusal diagnosis has been revolutionized in the last 
20 years, with ADN detection. With the routinely multi-
plex PCR technology use in community-acquired pneu-
monia diagnosis in child, the presence of mutiple virusal 
pathogens become a fact, with a rate of 30-40 percent of 4 
diff erent types at a single case7. 
Th e signifi cance of this multiple presence remain 
unclear6. For respiratory syncytial virus the coinfection 
with other viruses creates an increase severity of disease9. 
Recent identifi ed, human bocavirus was associated with 
a rate of 83 percent of coinfection, when the pathogen 
represents the etiologic factor per se or an exacerbation 
factor, or an accidental detection. Th is context remains 
unclear. Th e signifi cance threshold utilization for real-
time qPCR14 for estimative viral load has signifi cance in 
association with evidence clinics of a viral infection. 
Th e determination of viral etiology represents a challenge 
in countries where the molecular diagnosis is not routi-
nelly used. Th ere are some studies which demonstrated a 
high specifi city and a negative predictive value in detec-
tion of parainfl uenza and adenovirus from naso-pharyn-
geal aspirate, but a discordance between broncho-al-
veolar fl uid and naso-pharyngeal fl uid in detection of 
bacterial infection.
Concluzii. It is widely accepted the idea of bacterial infec-
tion that follow a viral one. Th e ideal bacterial identifi ca-
tion is that one which utilized a sample directly obtains 
by lung without any host fl ora contamination. It is very 
interesting the fact that the viral identifi cation from brin-
cho-alveolar aspirate has a lower rate comparing with 
naso-pharyngeal aspirate. Th e blood culture has a limited 
place (because a higher rate of false positive results). 
Stupum cultures have a limit regarding the modality of 
collection (aft er hypersaline solution nebulization or 
thoracic wall percussion, with the posibility of contami-
nation from upper airways). Conversely, the serologic 
tests are considerate the diagnosis gold-standard for 
bacterial pathogens (M. pneumoniae and S. pneumo-
niae). Th e last generation is considered the multilocular 
sequence, and for the future the technology of isothermal 
amplifi cation. 
Th ese molecular detection techniques brought major 
changes in the etiology of respiratory airways infection. 
What was believed in the past (bronchiolitis, due to 
respiratory syncytial virus, does not known the bacterial 
superinfection) seems to be not longer suoport today 
(respiratory syncytial virus not only are the favorizant 
factor for bacterial superinfection, but the coinfection 
produced a severe form of disease). 
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